TOP LATEST FIVE AT-56 URBAN NEWS

AT 56Compound sixty has a very significant affinity to MDM2 (Ki < 1 nM), strong mobile action, and an excellent oral pharmacokinetic profile. Compound 60 is capable of reaching full and very long-lasting tumor regression in vivo and it is at this time in section I medical trials for most cancers treatment.Species cross-reactivity needs to be invest